- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Seventy Percent of Liver Cancer Cases in the US Could be Prevented
GLI Spearheads Initiative to Double the Five-Year Survival Rate by 2030
Washington, DC — The Global Liver Institute (GLI), along with 33 other leading health and medical organizations, has issued a global call-to-action to increase the five-year survival rate for liver cancer from 18% to 36% by 2030.
Liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. In the United States this year alone more than 42,000 people will be diagnosed with liver cancer and more than 31,000 people will die from this disease. The National Cancer Institute estimates that there were more than 83,000 people living with liver cancer in the United States in 2016.
To read the full press release click here.
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More
